Investors Research Corp’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63 Hold
8
﹤0.01% 792
2026
Q1
$44 Hold
8
﹤0.01% 837
2025
Q4
$33 Hold
8
﹤0.01% 841
2025
Q3
$44 Hold
8
﹤0.01% 864
2025
Q2
$34 Hold
8
﹤0.01% 918
2025
Q1
$38 Hold
8
﹤0.01% 951
2024
Q4
$30 Hold
8
﹤0.01% 935
2024
Q3
$72 Hold
8
﹤0.01% 962
2024
Q2
$78 Hold
8
﹤0.01% 1043
2024
Q1
$108 Hold
8
﹤0.01% 1009
2023
Q4
$91 Hold
8
﹤0.01% 1044
2023
Q3
$85 Sell
8
-4
-33% -$61 ﹤0.01% 1055
2023
Q2
$184 Hold
12
﹤0.01% 1055
2023
Q1
$264 Hold
12
﹤0.01% 1082
2022
Q4
$417 Buy
12
+9
+300% +$356 ﹤0.01% 1084
2022
Q3
$0 Hold
3
﹤0.01% 1099
2022
Q2
$0 Hold
3
﹤0.01% 1096
2022
Q1
$0 Hold
3
﹤0.01% 1040
2021
Q4
$1K Hold
3
﹤0.01% 930
2021
Q3
$1K Hold
3
﹤0.01% 944
2021
Q2
$1K Hold
3
﹤0.01% 930
2021
Q1
$1K Sell
3
-1
-25% -$350 ﹤0.01% 924
2020
Q4
$1K Hold
4
﹤0.01% 1023
2020
Q3
$1K Buy
+4
New +$796 ﹤0.01% 1034

Other funds holding DTIL

Investors Research Corp's DTIL Position: Q2 2026 in Review

Investors Research Corp held its Precision BioSciences (DTIL) position steady in Q2 2026 at 8 shares worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Investors Research Corp first reported a position in DTIL in Q3 2020 and has held it in 24 quarters since. The position peaked at $1K in Q4 2021. 15 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Investors Research Corp held 8 shares of Precision BioSciences worth $63 as of Q2 2026.
  • Investors Research Corp left its Precision BioSciences share count unchanged in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Investors Research Corp's portfolio in Q2 2026, its #792 holding.
  • Investors Research Corp first reported a position in Precision BioSciences in Q3 2020 and has held it in 24 quarters since.
  • Investors Research Corp's Precision BioSciences position peaked at $1K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.